Compare · DCGO vs HIMS
DCGO vs HIMS
Side-by-side comparison of DocGo Inc. (DCGO) and Hims & Hers Health Inc. (HIMS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both DCGO and HIMS operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- HIMS is the larger of the two at $7.60B, about 118.2x DCGO ($64.3M).
- HIMS has been more active in the news (5 items in the past 4 weeks vs 1 for DCGO).
- HIMS has more recent analyst coverage (25 ratings vs 10 for DCGO).
- Company
- DocGo Inc.
- Hims & Hers Health Inc.
- Price
- -
- -
- Market cap
- $64.3M
- $7.60B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NYSE
- IPO
- 2020
- 2019
- News (4w)
- 1
- 5
- Recent ratings
- 10
- 25
DocGo Inc.
DocGo, Inc. provides mobile health services and integrated medical mobility solutions in 26 states in the United States and the United Kingdom. The company's AI-powered transportation and concierge medical services enable its clinical professionals to facilitate patient-centered care, helping improve patient outcomes while reducing the total cost of care for its customers. It also provides medical transport services. As of October 1, 2021, the company had 3,500 medical providers. It serves facilities, hospital networks, and health insurance providers. The company was founded in 2015 and is headquartered in New York, New York.
Hims & Hers Health Inc.
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available for purchase on its websites directly by customers. It provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, as well as cosmetics and supplement products, primarily focusing on wellness, sexual health, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, collagen protein, biotin, and teas in the wellness category; moisturizer, fragrances, face wash, and anti-wrinkle creams in the skincare category; condoms and lubricants in the sexual health category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. It also offers medical consultation services; and engages in the wholesale of non-prescription product sales to retailers. Hims & Hers Health, Inc. is based in San Francisco, California.
Latest DCGO
- DocGo Inc. filed SEC Form 8-K: Regulation FD Disclosure
- DocGo Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- DocGo Launches Mobile Phlebotomy Services in South Florida
- DocGo Announces Upcoming Participation at the Goldman Sachs 47th Annual Global Healthcare Conference
- Chief Executive Officer Bienstock Lee covered exercise/tax liability with 15,644 shares, decreasing direct ownership by 0.56% to 2,801,826 units (SEC Form 4)
- SEC Form 10-Q filed by DocGo Inc.
- DocGo Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- DocGo Announces First Quarter 2026 Results
- DocGo Announces Upcoming Participation at the 21st Annual Needham Technology, Media, & Consumer Conference
- DocGo to Announce First Quarter 2026 Results on Monday, May 11, 2026
Latest HIMS
- Hims & Hers Chief Accounting Officer, Irene Becklund, Announces Departure from the Company
- Hims & Hers Health Inc. filed SEC Form 8-K: Leadership Update
- Hims & Hers to Announce Second Quarter 2026 Financial Results on August 10, 2026
- Chief Financial Officer Okupe Oluyemi exercised 7,163 shares at a strike of $5.01 and sold $261,351 worth of shares (7,163 units at $36.49) as part of a pre-agreed trading plan (SEC Form 4)
- Hims & Hers Health Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- Chief Medical Officer Carroll Patrick Harrison sold $830,410 worth of shares (23,726 units at $35.00), decreasing direct ownership by 12% to 181,861 units (SEC Form 4)
- Chief Financial Officer Okupe Oluyemi exercised 6,376 shares at a strike of $5.01 and sold $619,217 worth of shares (18,197 units at $34.03) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 284,321 units (SEC Form 4)
- Chief Financial Officer Okupe Oluyemi converted options into 71,616 shares and covered exercise/tax liability with 39,541 shares, increasing direct ownership by 12% to 296,142 units (SEC Form 4) to cover withholding tax
- Chief Medical Officer Carroll Patrick Harrison converted options into 25,926 shares and covered exercise/tax liability with 8,310 shares, increasing direct ownership by 9% to 205,587 units (SEC Form 4) (withholding tax)
- Chief Operating Officer Chi Michael covered exercise/tax liability with 47,699 shares, sold $441,850 worth of shares (14,027 units at $31.50) as part of a pre-agreed trading plan and converted options into 86,264 shares, increasing direct ownership by 6% to 432,124 units (SEC Form 4) (withholding obligation)